The Most Pervasive Problems In ADHD Medication Pregnancy
adhd medication guide Medication During Pregnancy and Breastfeeding
Women with ADHD face a difficult decision regarding whether or not to stop taking ADHD medication during pregnancy and breast-feeding. There is a lack of information about how long-term exposure to these drugs may affect the fetus.
A study recently published in Molecular Psychiatry demonstrates that children exposed to ADHD medication during pregnancy do not develop neurological issues such as impaired hearing or vision, febrile seizures or IQ impairment. The authors acknowledge the need for higher-quality research.
Risk/Benefit Analysis
Pregnant women who take ADHD medications must weigh the advantages of taking them against potential risks to the fetus. Physicians don't have the necessary data to give clear guidelines but they can provide information on risks and benefits that aid pregnant women in making informed decisions.
A study published in Molecular Psychiatry found that women who took ADHD medications during their early pregnancy did not have a significantly increased risk of fetal heart malformations or major birth defects that are structural. Researchers conducted a massive population-based case control study to assess the frequency of major structural defects in infants who were born to mothers who took stimulants during pregnancy. Clinical geneticists, pediatric cardiologists and other experts examined the cases to confirm that the classification was accurate and to minimize any bias.
The study conducted by the researchers had some limitations. The most important issue was that they were not able to differentiate the effects of the medication from those of the underlying disorder. That limitation makes it difficult to determine whether the small associations observed in the groups that were exposed are due to medication use or the confounding effect of comorbidities. Researchers also did not look at long-term outcomes for the offspring.
The study did reveal that infants whose mothers took adhd and anxiety medication medication during pregnancy were at a slightly greater risk of being admitted to the neonatal intensive care unit (NICU) than those who were born without any medication or cut back on their medications prior to or during pregnancy. This was due to central nervous system-related disorders, and the increased risk of admission did not appear to be influenced by which stimulant medication was used during pregnancy.
Women who were taking stimulant ADHD medications during pregnancy also had a higher risk of having to have caesarean sections or the baby was not scoring well on the Apgar scale (less than 7). These increases didn't seem to be influenced by the type of medication that was used during pregnancy.
The research suggests that the low risk associated with the use of ADHD medications during the early stages of pregnancy could be offset by the greater benefit to both mother and child of continuing treatment for the woman's condition. Physicians should discuss this with their patients and, when possible, assist them in developing strategies to improve coping skills which can reduce the impact of her disorder on her daily life and relationships.
Medication Interactions
As more women than ever before are being diagnosed with ADHD and being treated with medication, the dilemma of whether or not to stop treatment during pregnancy is a question that more and more physicians face. Often, these decisions are taken in the absence of any evidence that is clear and definitive either way, so physicians must weigh their knowledge about their experiences, the experiences of other doctors, and what research says on the topic and their own judgments for each individual patient.
The issue of potential risks to infants is difficult to determine. Many of the studies on this subject are based on observational evidence rather than controlled research, and their conclusions are often contradictory. The majority of studies limit their analysis to live-births, which could underestimate the severity of teratogenic effects that can lead to terminations or abortions of pregnancy. The study presented in this journal club addresses these limitations by analyzing data on live and deceased births.
The conclusion is that while certain studies have demonstrated a positive association between ADHD medications and the possibility of certain birth defects, other studies have found no such relationship and the majority of studies have a neutral or slight negative effect. Therefore, a careful risk/benefit analysis must be done in each instance.
It isn't easy, but not impossible, for women suffering from ADHD to stop taking their medication for adhd. In a recent article in Archives of Women's Mental Health by psychologist Jennifer Russell, she notes that stopping ADHD medications during pregnancy can cause depression and feelings of being isolated. In addition, a decrease in medication may affect the ability to complete work-related tasks and safely drive which are essential aspects of daily life for many people with adhd medication pregnancy.
She suggests women who are uncertain about whether to keep or stop taking medication because of their pregnancy consider educating family members, friends and colleagues on the condition, its impact on daily functioning, and on the benefits of keeping the current treatment regimen. It will also help a woman feel more confident in her decision. It is important to note that some medications are able to pass through the placenta so if a woman decides to stop her ADHD medication during pregnancy and breastfeeding, she must be aware of the possibility that traces of the drug could be passed on to the baby.
Risk of Birth Defects
As the use of ADHD medications to treat symptoms of attention deficit hyperactivity disorder (ADHD) increases as do concerns about what impact the drugs could have on fetuses. Recent research published in the journal Molecular Psychiatry has added to the body of knowledge on this issue. Using two massive data sets, researchers were able to analyze more than 4.3 million pregnancies and see whether stimulant medications increased the risk of birth defects. Researchers discovered that, while the risk overall is low, the first trimester ADHD medication exposure was associated with slightly higher risk of specific heart defects like ventriculoseptal defects.
The researchers of the study found no link between early use of medication and other congenital abnormalities, like facial clefting, or club foot. The results are consistent with previous studies showing a small but significant increase in the risk of developing cardiac malformations among women who began taking ADHD medications before the time of pregnancy. This risk increased during the latter part of pregnancy, when many women are forced to stop taking their intuniv adhd medication medications.
Women who took ADHD medication during the first trimester were more likely to need a caesarean, have an insufficient Apgar after delivery, and have a baby who needed breathing assistance when they were born. The authors of the study were not able to eliminate selection bias because they limited the study to women with no other medical conditions that might have contributed to the findings.
The researchers hope that their research will serve to inform the clinical decisions of doctors who see pregnant women. The researchers advise that, while discussing the risks and benefits are important, the choice on whether to continue or stop medication should be according to the severity of each woman's ADHD symptoms and her requirements.
The authors caution that, even though stopping the medication is a possibility to consider, it is not recommended due to the high prevalence of depression and mental health issues among women who are pregnant or recently gave birth. Research has also shown that women who stop taking their medication will have a harder time adjusting to a life without them once the baby is born.
Nursing
The responsibilities that come with being a new mother can be overwhelming. Women with ADHD who have to manage their symptoms while attending doctor appointments as well as making preparations for the arrival of a child and getting used to new routines at home are often faced with a number of difficulties. Therefore, many women elect to continue taking their ADHD medication throughout the pregnancy.
The majority of stimulant drugs pass through breast milk in very small quantities, so the risk to the infant who is breastfeeding is low. The amount of exposure to medications will vary based on the dosage the medication is administered, its frequency and the time of day. In addition, various medications enter the baby’s system through the gastrointestinal tract or breast milk. The impact of these medications on a newborn's health is not completely comprehended.
Due to the absence of evidence, some doctors may recommend stopping stimulant medication during a woman's pregnancy. It is a difficult decision for the woman, who must weigh the benefits of taking her medication as well as the risk to the foetus. As long as there is no more information, doctors should inquire with all pregnant patients about their experience with ADHD and if they are planning or taking to take medication during the perinatal time.
A increasing number of studies have proven that most women can safely continue taking their ADHD medication during pregnancy and breastfeeding. In response, a growing number of patients are choosing to do this. They have concluded through consultation with their physicians, that the benefits of keeping their current medication outweigh potential risks.
It's important for women with ADHD who are contemplating breastfeeding to seek a specialist psychiatrist's advice prior becoming pregnant. They should review their medications with their prescriber and discuss the pros and cons of continued treatment, including non-pharmacological strategies. Psychoeducation should also be offered to help pregnant women suffering from ADHD recognize their symptoms and underlying disorder Learn about the available treatments and to reinforce existing strategies for coping. This should involve a multidisciplinary approach, which includes the GP as well as obstetricians, psychiatry and obstetricians. Pregnancy counseling should include discussion of a treatment plan for the mother and child, monitoring of signs of deterioration, and, if necessary modifications to the medication regime.